PAK1 and Hyperinsulinemia: It is likely that chronic inflammation and hyperinsulinemia associated with T2DM [2,62,63] may both lead to pancreatic and peripheral PAK kinase activation, in addition to reduction in total PAK protein levels, as PAK1 activation was previously described to down regulate itself after activation [64].